XSO

N-{5-[4-(2-amino-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]-3-fluoropyridine-2-carbonyl}-L-glutamic acid

Created:	2022-12-06
Last modified:	2023-05-10

Find Related PDB Entry
1 entries where XSO is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	56
Chiral Atom Count	1
Bond Count	58
Aromatic Bond Count	11

2D diagram of XSO

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{5-[4-(2-amino-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-6-yl)butyl]-3-fluoropyridine-2-carbonyl}-L-glutamic acid
Systematic Name (OpenEye OEToolkits)	(2~{S})-2-[[5-[4-(2-azanyl-4-oxidanylidene-1~{H}-thieno[2,3-d]pyrimidin-6-yl)butyl]-3-fluoranyl-pyridin-2-yl]carbonylamino]pentanedioic acid
Formula	C₂₁ H₂₂ F N₅ O₆ S
Molecular Weight	491.493
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)C(CCC(=O)O)NC(=O)c1ncc(cc1F)CCCCc1cc2C(=O)N=C(N)Nc2s1
SMILES	CACTVS	3.385	NC1=NC(=O)c2cc(CCCCc3cnc(C(=O)N[CH](CCC(O)=O)C(O)=O)c(F)c3)sc2N1
SMILES	OpenEye OEToolkits	2.0.7	c1c(cnc(c1F)C(=O)NC(CCC(=O)O)C(=O)O)CCCCc2cc3c(s2)NC(=NC3=O)N
Canonical SMILES	CACTVS	3.385	NC1=NC(=O)c2cc(CCCCc3cnc(C(=O)N[C@@H](CCC(O)=O)C(O)=O)c(F)c3)sc2N1
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1c(cnc(c1F)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CCCCc2cc3c(s2)NC(=NC3=O)N
InChI	InChI	1.06	InChI=1S/C21H22FN5O6S/c22-13-7-10(9-24-16(13)18(31)25-14(20(32)33)5-6-15(28)29)3-1-2-4-11-8-12-17(30)26-21(23)27-19(12)34-11/h7-9,14H,1-6H2,(H,25,31)(H,28,29)(H,32,33)(H3,23,26,27,30)/t14-/m0/s1
InChIKey	InChI	1.06	USGRXMVHCFOWQP-AWEZNQCLSA-N

Related Resource References

Resource Name	Reference
PubChem	168010755

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.